Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 1Phase 2/3 1

Status

Completed 13Unknown 4Terminated 3Recruiting 2Withdrawn 1

Sponsor Class

OTHER 3UNKNOWN 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Gastrointestinal 1

Conditions

Vomiting 3Nausea 3Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Radiation Injuries 1Lung Neoplasms 1

Interventions

Cisplatin 270Oxaliplatin 195Carboplatin 191Capecitabine 184Docetaxel 178apatinib 164Paclitaxel 163Bevacizumab 159Gemcitabine 156Radiotherapy 147camrelizumab 146Fluorouracil 144Cyclophosphamide 126Irinotecan 120Drug Therapy 119sintilimab 108Etoposide 99anlotinib 90S 1 (combination) 89Leucovorin 86pembrolizumab 85toripalimab 78Pemetrexed 78Doxorubicin 77tislelizumab 76Dexamethasone 71Trastuzumab 65Neoadjuvant Therapy 65Rituximab 62Cetuximab 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Unknown × Palonosetron × Clear all
NCT04308837 2023-11-14

A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation

Icahn School of Medicine at Mount Sinai

Phase 2 Unknown
29 enrolled
Gastrointestinal

Stomach Neoplasms

NCT05202275 2022-01-21

The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs

ChineseAMS

Phase 2 Unknown
43 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nausea, Radiation Injuries, Vomiting

NCT02445872 2015-12-09

Safety and Efficacy of Aprepitant for CINV in Patients With Lung Cancer Receiving Multiple-day Cisplatin Chemotherapy

Zhejiang University

Phase 2 Unknown
80 enrolled
Thoracic

Lung Neoplasms, Nausea, Vomiting

NCT02290470 2014-11-14

Olanzapine Against Delayed Nausea and Vomiting in Women Receiving Carboplatin Plus Paclitaxel

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown
81 enrolled

Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡